PsychedeliCare initiative registered by the European Commission

The PsychedeliCare European Citizens’ Initiative has been officially registered by the European Commission.

The European Citizens' Initiative is a mechanism that allows EU citizens to propose new legislation by gathering one million signatures from at least seven EU Member States, prompting the European Commission to consider and potentially act on the initiative.

The PsychedeliCare calls on the Commission to:

  • Develop expert consensus on psychedelic care standards and help integrate psychedelic therapies into European healthcare systems.

  • Promote multidisciplinary training and capacity-building efforts for healthcare professionals working in this field.

  • Foster research into the therapeutic uses of psychedelics and establish European research networks.

  • Advocate for common positions at the international level to support the regulation of psychedelic compounds.

The European Commission noted that this initiative aligns with current EU public health objectives, particularly in addressing mental health challenges. 

PAREA has been pleased to support this initiative since its early stages and we assisted its leaders with developing the key asks. 

What’s next? The PsychedeliCare team is preparing for the launch event which needs to take place within the next six months. After the launch, we will have one year to gather 1 million signatures across the 27 EU Member States.

Previous
Previous

Advocating for mental health innovation: PAREA’s push in Brussels

Next
Next

PAREA proud to attend the HOPE Summit in Washington DC